Circle pushes blockchain Arc to be quantum-resistant, Q-Day may arrive before 2030
According to ChainCatcher, stablecoin issuer Circle stated that its upcoming Layer 1 network, Arc, will be designed with quantum resistance as a core objective, emphasizing that long-term cryptographic security has become a “baseline requirement” for financial infrastructure. “Q-Day” (the critical point when quantum computing can break public key cryptography) could arrive before 2030, or even sooner. At the same time, attackers have already begun collecting data in advance, intending to decrypt it once quantum computing matures, with potential risks already emerging.
The Arc testnet went live in October 2025, and the mainnet is expected to launch within the year. In its initial phase, it will support quantum-resistant signature schemes, allowing users to create quantum-resistant wallets (not mandatory). In the future, it will also expand to cover transaction privacy protections, including the encryption of balances, recipients, and transaction data. In the long term, Arc also plans to introduce quantum resistance mechanisms at the validator authentication and network infrastructure levels, aiming to build a comprehensive protection system. Circle stated that Arc is intended to offer developers and institutions a practical path for a smooth transition to the post-quantum era, not just a theoretical concept.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.

WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

